2 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Stage I Hypopharyngeal Carcinoma AJCC v8: new trials by email Literature Review of Stage I Hypopharyngeal Carcinoma AJCC v8 trials Research Report on Stage I Hypopharyngeal Carcinoma AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer Best Practice, Biospecimen Collection, Cisplatin - Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Recruiting | NRG Oncology | 98 | 2025-06-23 | 2026-08-17 |
| Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer Biospecimen Collection, Questionnaire Administration - Carcinoma of Unknown Primary, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Recruiting | M.D. Anderson Cancer Center | 471 | 2016-12-29 | 2026-10-06 |
Carcinoma (2) · Hypopharyngeal Neoplasms (2) · Laryngeal Neoplasms (2) · Nasopharyngeal Carcinoma (2) · Oropharyngeal Neoplasms (2) · Mouth Neoplasms (1) · Neoplasms, Unknown Primary (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomatitis (1)
Head and Neck Neoplasms (2) · Laryngeal Diseases (2) · Nasopharyngeal Diseases (2) · Nasopharyngeal Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Otorhinolaryngologic Diseases (2) · Otorhinolaryngologic Neoplasms (2) · Pharyngeal Diseases (2) · Pharyngeal Neoplasms (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Stomatognathic Diseases (2)
1,2-diaminocyclohexaneplatinum II citrate (1) · Cisplatin (1) · Magnetic Resonance Spectroscopy (1) · Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin (1) · Platinum (1) · Practice Guidelines as Topic (1) · Radiotherapy, Image-Guided (1) · Radiotherapy, Intensity-Modulated (1) · Specimen Handling (1) · Standard of Care (1)
M.D. Anderson Cancer Center (1) · NRG Oncology (1)
United States (2)
David M Brizel (1) · Eileen H Shinn (1)
R21DE019954 (1), UG1CA189867 (1)